These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 8575754)
1. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases. Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754 [TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of murine p16INK4a and p15INK4b genes. Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726 [TBL] [Abstract][Full Text] [Related]
3. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Gilley J; Fried M Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876 [TBL] [Abstract][Full Text] [Related]
4. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237 [TBL] [Abstract][Full Text] [Related]
5. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths. Renner C; Baumgartner R; Noegel AA; Holak TA J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685 [TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia. Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092 [TBL] [Abstract][Full Text] [Related]
8. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors. Zariwala M; Xiong Y Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Suzuki T; Narita T; Uchida-Toita M; Yoshida M Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662 [TBL] [Abstract][Full Text] [Related]
10. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Fink JR; LeBien TW Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189 [TBL] [Abstract][Full Text] [Related]
11. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors. Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782 [TBL] [Abstract][Full Text] [Related]
12. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Zindy F; Quelle DE; Roussel MF; Sherr CJ Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Schreiber M; Muller WJ; Singh G; Graham FL Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428 [TBL] [Abstract][Full Text] [Related]
14. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987 [TBL] [Abstract][Full Text] [Related]
15. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052 [TBL] [Abstract][Full Text] [Related]
16. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766 [TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias. Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234 [TBL] [Abstract][Full Text] [Related]
18. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P; Schmidt M; Hu X; Wolff L Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863 [TBL] [Abstract][Full Text] [Related]
19. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias. Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199 [TBL] [Abstract][Full Text] [Related]
20. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Knapek DF; Serrano M; Beach D; Trono D; Walker CL Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]